The true cost of pharmacological disease prevention

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British medical journal

• Publication date

  2011-04-19

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1136/bmj.d2175PMID 21505222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design

  2010cited by this paper
• A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents

  2010cited by this paper
• The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

  2010cited by this paper
• The routine use of patient reported outcome measures in healthcare settings

  2010cited by this paper
• Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

  2009cited by this paper
• Comparing Adherence and Persistence Across 6 Chronic Medication Classes

  2009cited by this paper
• Comparative Effectiveness Research: A Report From the Institute of Medicine

  2009cited by this paper
• Pharmacological Management of Osteoporosis in Nursing Home Populations: A Systematic Review

  2009cited by this paper
• A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example

  2009cited by this paper
• New tool measures 10-year fracture risk.

  2008cited by this paper
• Shifting the focus in fracture prevention from osteoporosis to falls

  2008cited by this paper
• Nationwide Decline in Incidence of Hip Fracture

  2006cited by this paper
• Compliance with osteoporosis therapy is the weakest link.

  2006cited by this paper
• An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

  2006cited by this paper
• BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long‐Term Results From the Study of Osteoporotic Fractures

  2003cited by this paper
• Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls. 2: Controlled trial in multiple centres

  2001cited by this paper
• Can it work? Does it work? Is it worth it?

  1999cited by this paper
• 96153999 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996cited by this paper
• Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996cited by this paper

• Editor's Spotlight/Take 5: Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery: An Economic Evaluation Based on the FIDELITY Trial Data.

  2024cites this paper
• Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence.

  2022cites this paper
• The surgical approach to ipsilateral mediastinal (N2) nodes at the time of lobectomy for lung cancer

  2021cites this paper
• Feasibility of effectiveness trials in pediatric anesthesia

  2021cites this paper
• A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial

  2021cites this paper
• Reduced Risk of Reoperation Using Intramedullary Nailing with Femoral Neck Protection in Low-Energy Femoral Shaft Fractures.

  2020cites this paper
• Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial

  2020cites this paper
• Wo sich Wissenschaft und Praxis treffen: anwendungsorientierte Forschung in Bewegungstherapie und Gesundheitssport – eine Einführung

  2020cites this paper
• Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom

  2019cites this paper
• An evaluation of usability of warp knitted spacer fabrics as hip protector

  2018cites this paper
• Reviving Cochrane's contribution to evidence‐based medicine: bridging the gap between evidence of efficacy and evidence of effectiveness and cost‐effectiveness

  2017cites this paper
• Finnish Subacromial Impingement Arthroscopy Controlled Trial (FIMPACT): a protocol for a randomised trial comparing arthroscopic subacromial decompression and diagnostic arthroscopy (placebo control), with an exercise therapy control, in the treatment of shoulder impingement syndrome

  2017cites this paper
• Mechanical Symptoms and Arthroscopic Partial Meniscectomy in Patients With Degenerative Meniscus Tear: A Secondary Analysis of a Randomized Trial.

  2016cites this paper
• The Importance of a Registry in Spinal Surgery

  2016cites this paper
• 2015 Outstanding Paper Winner: Surgical Science Total disc arthroplasty versus anterior cervical interbody fusion: use of the Spine Tango registry to supplement the evidence from randomized control trials

  2016cites this paper
• Is Surgery Warranted for Oligometastatic Disease?

  2016cites this paper
• Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

  2016cites this paper
• Videothoracoscopic resection for lung cancer: moving towards a "standard of care".

  2016cites this paper
• Healing Practices and Evidence-Based Medicine

  2016cites this paper
• Both falling and bone fragility should be targeted to prevent hip fracture in older adults

  2016cites this paper
• SVRSISHODNOST PREVENTIVNOG LIJEČENJA EFFICIENCY OF PREVENTIVE TREATMENT

  2016cites this paper
• Analysis of pulmonary metastasis as an indication for operation: an evidence-based approach.

  2016cites this paper
• Total disc arthroplasty versus anterior cervical interbody fusion: use of the Spine Tango registry to supplement the evidence from randomized control trials.

  2016cites this paper
• Authors’ reply to Lee and colleagues

  2015cites this paper
• Danish register-based study on the association between specific cardiovascular drugs and fragility fractures

  2015cites this paper
• Unmasking the surgeons: the evidence base behind the use of facemasks in surgery

  2015cites this paper
• Osteoporosis: the emperor has no clothes

  2015cites this paper
• Hip Protectors: Are They Worth it?

  2015cites this paper
• Meta‐audit of laboratory ISO accreditation inspections: measuring the old emperor's clothes

  2015cites this paper
• Multicentre randomized clinical trial to investigate the cost‐effectiveness of an allogeneic single‐donor fibrin sealant after coronary artery bypass grafting (FIBER Study)

  2015cites this paper
• Fifteen years in the evaluation of extrapleural pneumonectomy: Lessons to be learned.

  2015cites this paper
• Do We Need a Science of Science

  2015cites this paper
• How Medical Practice Has Gone Wrong: Causes of the Lack-of-Reproducibility Crisis in Medical Research

  2015cites this paper
• Overdiagnosis of bone fragility in the quest to prevent hip fracture

  2015cites this paper
• El rol de la investigación en efectividad comparada (CER)

  2015cites this paper
• Arthroscopy for Degenerative Meniscus Tear

  2014cites this paper
• Clinical Trials with Surrogate Outcomes Have Brought Bad Medicine(s)

  2014cites this paper
• Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol

  2014cites this paper
• Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: Retrospective analysis of safety profile and effect on blood coagulation

  2014cites this paper
• Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view.

  2014cites this paper
• A positive viewpoint regarding arthroscopy for degenerative knee conditions

  2014cites this paper
• Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study

  2014cites this paper
• Suction on chest drains following lung resection: evidence and practice are not aligned.

  2014cites this paper
• The failings of modern medicine.

  2014cites this paper
• Author reply: To PMID 24800623.

  2014cites this paper
• Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women

  2013cites this paper
• Efficacy versus effectiveness trials: informing guidelines for asthma management

  2013cites this paper
• Rethinking policy-related research: charting a path using qualitative comparative analysis and complexity theory

  2013cites this paper
• Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors

  2012cites this paper
• Il sano malato: un ossimoro tra “disease mongering” e il sogno di Henry Gadsden

  2012cites this paper
• Surrogates under scrutiny: fallible correlations, fatal consequences

  2011cites this paper
• Does Medicalization of Life Imperil Health? Expanding Indications for Diagnosis and Treatment of Chronic “Disease”

  2011cites this paper
• Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness

  2011cites this paper
• Dare to tell?

  2011cites this paper
• As different as Venus and Mars: time to distinguish efficacy (can it work?) from effectiveness (does it work?)

  2011cites this paper
• The case for diabetes screening: ADDITION-Europe.

  2011cites this paper
• The irrelevance of statistics-based research to individual patients

  2011cites this paper